Enzyme replacement therapy in late-onset type II glycogenosis

Eur J Neurol. 2009 Jul;16(7):e124. doi: 10.1111/j.1468-1331.2009.02664.x. Epub 2009 May 22.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Glycogen Storage Disease Type II / physiopathology
  • Glycogen Storage Disease Type II / therapy*
  • Humans
  • Vital Capacity / drug effects
  • Vital Capacity / physiology
  • alpha-Glucosidases / therapeutic use*

Substances

  • alpha-Glucosidases